The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    Status of cannabinoids for pain management

    Dr. Lynn Webster of the Lifetree Pain Clinic in Salt Lake City, Utah reports from the American Academy of Pain Medicine meeting.


    “Newer compounds show promise for analgesic efficacy while reducing common side effects of dizziness, euphoria, fatigue, and nausea.”

    Sativex is an oral spray containing 2.7 mg of delta-9-tetrahydrocannabinol (THC) and 2.5 mg of cannabidiol (CBD).

    • Including CBD appears to reduce the psychoactive effects of THC.
    • Intoxication was less than with oral THC, according to presenters at the meeting.
    • With Sativex, patients can control the amount they use, with a resulting dose of approximately 20-30 mg/day of both THC and CBD.

    Sativex is approved for use in Canada and being studied in the US. The situation in the UK appears political.

    6/14/07 23:13 JR

    Leave a Comment

    You must be logged in to post a comment.